Review article · 2011 · Open access

The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer

Taj D. King, Mark J. Suto, Yonghe Li

Journal of Cellular Biochemistry, 113(1), 13–18 · Published 9 December 2011 · DOI 10.1002/jcb.23350

Open PDFView at the publisherCite this paper

In brief

“The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer” is a 2011 review article by Taj D. King and 2 co-authors, published in Journal of Cellular Biochemistry. OpenAlex counts 318 citations as of 21 November 2026, which puts it in the top 1% of works published in 2011 by citations. It is open access: the full text is free to read at PubMed Central.

Citations
318
Most cited in
2021 (37)
Field-weighted impact
1.33
References
49
Authors
3

Abstract

Breast cancer continues to be a serious health problem particularly in developed countries. Of particular concern is triple negative breast cancer (TNBC) which does not respond well to standard hormone therapy and is associated with poor overall patient prognosis. Recent studies indicate that Wnt/β-catenin signaling is particularly activated in TNBC, such that the Wnt receptor frizzled-7 (FZD7) and the Wnt co-receptor LRP6 were found to be up regulated in TNBC. In addition, it has been demonstrated that transcriptional knockdown of LRP6 or FZD7 in TNBC cells suppressed tumor growth in vivo. Furthermore, salinomycin, a selective breast cancer stem cell killer, was recently demonstrated to be an inhibitor of Wnt/β-catenin signaling by inducing LRP6 degradation. Therefore, the Wnt/β-catenin signaling pathway and particularly the Wnt receptors on the cell surface may serve as novel therapeutic targets for the treatment of TNBC.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

King, T. D., Suto, M. J., & Li, Y. (2011). The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer. Journal of Cellular Biochemistry, 113(1), 13–18. https://doi.org/10.1002/jcb.23350

MLA 9

King, Taj D., et al. “The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer.” Journal of Cellular Biochemistry, vol. 113, no. 1, 2011, pp. 13–18. https://doi.org/10.1002/jcb.23350.

Chicago

King, Taj D., Mark J. Suto, and Yonghe Li. 2011. “The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer.” Journal of Cellular Biochemistry 113 (1): 13–18. https://doi.org/10.1002/jcb.23350.

Harvard

King, T. D., Suto, M. J. and Li, Y. (2011) ‘The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer’, Journal of Cellular Biochemistry, 113(1), pp. 13–18. doi:10.1002/jcb.23350.

IEEE

T. D. King, M. J. Suto, and Y. Li, “The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer,” Journal of Cellular Biochemistry, vol. 113, no. 1, pp. 13–18, 2011, doi: 10.1002/jcb.23350.

BibTeX

@article{king2011catenin,
  title     = {{The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer}},
  author    = {King, Taj D. and Suto, Mark J. and Li, Yonghe},
  journal   = {Journal of Cellular Biochemistry},
  year      = {2011},
  volume    = {113},
  number    = {1},
  pages     = {13--18},
  doi       = {10.1002/jcb.23350},
  url       = {https://doi.org/10.1002/jcb.23350}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20172525
20182727
20192424
20202424
20213737
20223333
20231212
20241010
20251616
202688

Its field-weighted citation impact is 1.33: it has been cited 1.33 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer

  • Wnt/β-catenin signaling
  • triple-negative breast cancer
  • FZD7
  • LRP6
  • salinomycin
  • breast cancer stem cells
  • therapeutic target
  • tumor growth inhibition

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

King, T. D., Suto, M. J., & Li, Y. (2011). The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer. Journal of Cellular Biochemistry, 113(1), 13–18. https://doi.org/10.1002/jcb.23350

How many times has this paper been cited?

318 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the PDF from this page.

Who wrote this paper?

Taj D. King, Mark J. Suto, Yonghe Li.

What is the DOI of this paper?

10.1002/jcb.23350, permanently at https://doi.org/10.1002/jcb.23350. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.